Patents: a necessary evil?
Dave Elder explores US patent developments amid growing concerns that current approaches may delay generic drugs and biosimilars entering the market.
United States United Kingdom City Of Dave Elder Acta Pharmaceutica Sinica Santa Clara High Technology Law Journal
Source: europeanpharmaceuticalreview.com